Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression.
Journal
Leukemia
ISSN: 1476-5551
Titre abrégé: Leukemia
Pays: England
ID NLM: 8704895
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
15
06
2022
accepted:
06
01
2023
revised:
06
11
2022
pubmed:
16
2
2023
medline:
10
3
2023
entrez:
15
2
2023
Statut:
ppublish
Résumé
Myelodysplastic syndromes (MDS) comprise hematological disorders that originate from the neoplastic transformation of hematopoietic stem cells (HSCs). However, discrimination between HSCs and their neoplastic counterparts in MDS-derived bone marrows (MDS-BMs) remains challenging. We hypothesized that in MDS patients immature CD34
Identifiants
pubmed: 36792658
doi: 10.1038/s41375-023-01811-5
pii: 10.1038/s41375-023-01811-5
pmc: PMC9991914
doi:
Substances chimiques
Antigens, CD34
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
680-690Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2018 Sep 12;9(1):3694
pubmed: 30209285
N Engl J Med. 2010 Sep 9;363(11):1025-37
pubmed: 20825315
Leuk Res. 2014 Jun;38(6):714-21
pubmed: 24746294
Cancer Cell. 2014 Jun 16;25(6):794-808
pubmed: 24835589
Leuk Lymphoma. 2006 Feb;47(2):207-22
pubmed: 16321850
N Engl J Med. 2009 Nov 5;361(19):1872-85
pubmed: 19890130
Leukemia. 2019 May;33(5):1102-1112
pubmed: 30542144
Leukemia. 2019 Jul;33(7):1747-1758
pubmed: 30635634
Haematologica. 2017 Mar;102(3):498-508
pubmed: 27884971
Blood. 2000 Sep 15;96(6):2012-21
pubmed: 10979941
Blood. 2005 Dec 15;106(13):4086-92
pubmed: 16131573
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5009-14
pubmed: 21383193
Leukemia. 2016 Feb;30(2):439-46
pubmed: 26437777
Br J Haematol. 2016 Nov;175(3):393-401
pubmed: 27612176
Leuk Res. 2018 Apr;67:12-16
pubmed: 29407181
Br J Haematol. 2016 Apr;173(2):219-35
pubmed: 26814163
Cytometry A. 2010 Sep;77(9):840-8
pubmed: 20662087
PLoS One. 2018 May 25;13(5):e0197823
pubmed: 29799854
Leuk Lymphoma. 2016;57(1):17-20
pubmed: 26098015
J Clin Oncol. 2012 Sep 20;30(27):3376-82
pubmed: 22869879
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3011-6
pubmed: 23388639
Blood. 2012 Sep 20;120(12):2454-65
pubmed: 22740453
Ann Hematol. 2022 Mar;101(3):571-579
pubmed: 35024892
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Nat Commun. 2015 Dec 08;6:10004
pubmed: 26643973
Blood. 2007 Oct 15;110(8):3005-14
pubmed: 17616640
Cytometry B Clin Cytom. 2021 Sep;100(5):574-589
pubmed: 33369070
Br J Haematol. 2020 Sep;190(6):891-900
pubmed: 32239670
Blood. 2012 Sep 6;120(10):2076-86
pubmed: 22753872
Blood. 2002 Jul 1;100(1):259-67
pubmed: 12070035
J Clin Invest. 2011 Jan;121(1):384-95
pubmed: 21157036
Blood. 2012 Aug 9;120(6):1290-8
pubmed: 22723552
Cytometry B Clin Cytom. 2020 Mar;98(2):131-145
pubmed: 31917512
Blood. 1997 Mar 15;89(6):2079-88
pubmed: 9058730
Int J Hematol. 2014 Jul;100(1):60-9
pubmed: 24846193
Eur J Cancer. 2014 Mar;50(5):1004-12
pubmed: 24388662
PLoS One. 2014 Sep 22;9(9):e107587
pubmed: 25244440
Nat Med. 2019 Jan;25(1):103-110
pubmed: 30510255